Jason Pitofsky's most recent trade in Regeneron Pharmaceuticals, Inc. was a trade of 298 Common Stock done at an average price of $730.8 . Disclosure was reported to the exchange on Dec. 16, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Regeneron Pharma | Jason Pitofsky | VP Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 730.81 per share. | 16 Dec 2024 | 298 | 4,664 (0%) | 0% | 730.8 | 217,781 | Common Stock |
| Regeneron Pharma | Jason Pitofsky | VP Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 3,236 | 3,236 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Jason Pitofsky | VP Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 907 | 5,111 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | Jason Pitofsky | VP Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 787.00 per share. | 06 Dec 2024 | 149 | 4,962 (0%) | 0% | 787 | 117,263 | Common Stock |
| Regeneron Pharma | Jason Pitofsky | VP Controller | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Dec 2024 | 90 | 179 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | Jason Pitofsky | VP Controller | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Dec 2024 | 89 | 89 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | Jason Pitofsky | VP Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2024 | 487 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Jason Pitofsky | VP Controller | Sale of securities on an exchange or to another person at price $ 1070.00 per share. | 07 Aug 2024 | 487 | 4,204 (0%) | 0% | 1070 | 521,090 | Common Stock |
| Regeneron Pharma | Jason Pitofsky | VP Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 372.46 per share. | 07 Aug 2024 | 487 | 4,691 (0%) | 0% | 372.5 | 181,388 | Common Stock |